Skip to main content

Chiron Real Estate Inc.

corporate_fare Company Profile

Chiron Real Estate Inc.

XRN·NYSE·Real Estate & Construction·CIK 0001533615

Chiron Real Estate Inc. is a Maryland corporation and an internally managed REIT that primarily acquires healthcare facilities. These facilities are leased to physician groups and regional and national healthcare systems. The company's common stock is listed on the New York Stock Exchange. On February 23, 2026, the company changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc. It elected to be taxed as a REIT for U.S. federal income tax purposes starting with its taxable year ended December 31, 2016. Chiron Real Estate Inc. holds its facilities and conducts operations through a Delaware limited partnership subsidiary, Chiron Real Estate LP. Its wholly owned subsidiary, Chiron Real Estate GP LLC, is the sole general partner of this Operating Partnership. As of December 31, 2025, Chiron Real Estate Inc. owned 92.0% of the outstanding common operating partnership units (OP Units) of its Operating Partnership. The remaining 8.0% of the Operating Partnership was owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services in exchange for OP Units. On September 19, 2025, the company completed a one-for-five reverse stock split of its outstanding common stock, with a corresponding adjustment to the outstanding partnership units of the Operating Partnership. The company's business strategy is to invest primarily in healthcare properties that offer an attractive rate of return relative to its cost of capital and are operated by profitable physician groups, regional or national healthcare systems, or combinations of these.

Chiron Real Estate Inc. (NYSE:XRN) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 21 items for XRN at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Chiron Real Estate Reports Mixed Q4 Results, Rebrands, Raises Capital, and Discloses Tenant Bankruptcy

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$148.21M
Net Income
-$6.88M
Diluted EPS
-$0.91
Op. Cash Flow
$73.61M
Cash & Equivalents
$9.08M
Total Debt
$1.15M
Debt / Equity
0.00×
Net Margin
-4.6%
Shares Outstanding
13.23M sh
Source: 10-K · filed 2026-03-02 · accession 0001104659-26-021956
$35.91
52-week range · as of 2026-08-17 $29.05 – $39.93
Market cap
$520.5M
Volume
140.6K (1.4× avg)
3-mo avg 99.7K
Live data · 2026-09-20 12:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XRN - Filings & News (Page 2)

XRN
Feb 25, 2026, 4:57 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.20
Real-time Price: $35.91 info
Change: -$1.29 (-3%) info
Market Cap: $520.503M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets